6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
10m ago	Stop the Rail Merger Coalition Launches to Oppose Union Pacific-Norfolk Southern Merger
11m ago	NorthEast Community Bancorp, Inc. Reports Results for the Three Months Ended March 31, 2026
11m ago	Better Home Equity Card Powered by Stripe Enables Easy Access to HELOC Funds and Introduces a Modern Access Layer Across the $21.4 Trillion Home Equity Market
1h ago	GridAI Technologies Corp. to Present at the Market Movers Investor Summit
1h ago	GLENSTAR DRILLING PROGRAM UPDATE AT WILDHORSE PROJECT CURRENTLY UNDERWAY IN NEVADA

About

Cosmo Pharmaceuticals Sa (SW:COPN) — investor relations, events, news, and company updates on 6ix.

Latest News

Phase III 12-Month Data for Clascoterone 5% Topical Solution Confirm Positive Safety for Chronic Use and Continued Hair Growth, both of which are Statistically Significant

Voting Results of Cosmo's 2026 AGM

Cosmo Highlights Leadership in Real Time Medical AI at NVIDIA GTC 2026

Cosmo Presents Agenda for AGM 2026

Cosmo Pharmaceuticals Achieves 104.2M Revenue and 9.5M EBITDA in 2025; Proposes 2.10 Dividend; Establishes 2026 Growth Framework

Financials

Revenue

CHF104.17 M

Market Cap

CHF1.49 B

EPS

-0.21

Dividend Yield

2.43%

Community Chat

Ask AI